Tasquinimod
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Tasquinimod, covering 2015-10-21 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) [Phase 1, Phase 2]